DAVID KOHN: Open Payments
NPI 1720556178 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 44 payments from 16 companies in 2025. Trend: 2023 $2,135 · 2024 $1,309 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $208 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| Almatica Pharma LLC | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 3 | $81 |
| Lundbeck LLC | 3 | $70 |
| Alkermes, Inc. | 3 | $68 |
| Corium, LLC | 2 | $59 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
| Bausch Health US, LLC | 3 | $55 |
Products named: Auvelity, REXULTI, LOREEV XR, COBENFY, Azstarys, Jornay PM, CAPLYTA, APLENZIN.
Industry payments across FL — which companies pay providers there.
